Comparative analysis of CK2 expression and function in tumor cell lines displaying sensitivity vs. resistance to chemical induced apoptosis
G. Di Maira, F. Brustolon, K. Tosoni, S. Belli, S.D. Krämer, L.A. Pinna and M. RuzzeneMolecular and Cellular Biochemistry (2008), Vol. 316 pages 155-61
Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2
J.S. Duncan and D.W. LitchfieldBiochimica et Biophysica Acta (2008), Vol. 1784 pages 33-47
Protein Kinase CK2 in Human Diseases
B. Guerra and O.G. IssingerCurrent Medicinal Chemistry (2008), Vol. 15 pages 1870-1886
Inhibition of casein kinase 2 enhances the death ligand- and natural killer cell-induced hepatocellular carcinoma cell death
H.R. Kim, K. Kim, K.H. Lee, S.J. Kim and J. KimClinical and Experimental Immunology (2008), Vol. 152 pages 336-344
CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells
D. Llobet, N. Eritja, M. Encinas, N. Llecha, A. Yeramian, J. Pallares, A. Sorolla, F.J. Gonzalez-Tallada, X. Matias-Guiu and X. DolcetOncogene (2008), Vol. 27 pages 2513-2524
CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo
S.E. Perea, O. Reyes, I. Baladron, Y. Perera, H. Farina, J. Gil, A. Rodriguez, D. Bacardi, J.L. Marcelo, K. Cosme, M. Cruz, C. Valenzuela, P.A. López-Saura, Y. Puchades, J.M. Serrano, O. Mendoza, L. Castellanos, A. Sanchez, L. Betancourt, V. Besada, R. Silva, E. López, V. Falcón, I. Hernández, M. Solares, A. Santana, A. Díz, T. Ramos, C. López, J. Ariosa, L.J. González, H. Garay, D. Gómez, R. Gómez, D.F. Alonso, H. Sigman, L. Herrera and B. AcevedoMolecular and Cellular Biochemistry (2008), Vol. 316 pages 163-167
Systemic administration of a peptide that impairs the Protein Kinase (CK2) phosphorylation reduces solid tumor growth in mice
Y. Perera, H.G. Farina, I. Hernádez, O. Mendoza, J.M. Serrano, O. Reyes, D.E. Gómez, R.E. Gómez, B.E. Acevedo, D.F. Alonso and S.E. PereaInternational Journal of Cancer (2008), Vol. 122 pages 57-62
Protein kinase CK2 as a druggable target
S. Sarno and L.A. PinnaMolecular BioSystems (2008), Vol. 4 pages 889-894
Impact of protein kinase CK2 on inhibitor of apoptosis proteins in prostate cancer cells
G. Wang, K.A. Ahmad, N.H. Harris and K. AhmedMolecular and Cellular Biochemistry (2008), Vol. 316 pages 91-97
Casein kinase II inhibition induces apoptosis in pancreatic cancer cells
R. Hamacher, D. Saur, R. Fritsch, M. Reichert, R.M. Schmid and G. SchneiderOncology Reports (2007), Vol. 18 pages 695-701
Protein Kinase CK2α as an Unfavorable Prognostic Marker and Novel Therapeutic Target in Acute Myeloid Leukemia
J.S. Kim, J.I. Eom, J-W Cheong, A.J. Choi, J.K. Lee, W.I. Yang and Y.H. MinClinical Cancer Research (2007), Vol. 13 pages 1019-1028